Regional Viral Hepatitis Webinar 2: The Diagnostic and Prognostic Roles of M2PBGi in Patients with Hepatocellular Carcinoma
Speaker
Prof. Pisit Tangkijvanich, M.D.
Professor (Head of Department), Biochemistry,
Faculty of Medicine Chulalongkorn University, Thailand
President, Thai Association for the Study of the Liver (THASL)
Moderator
Tan Swee Jin, PhD, PMP
Senior Manager, Scientific Affairs, Sysmex Asia Pacific
Abstract
Serum Mac-2 binding protein glycosylation isomer (M2BPGi) is a novel biomarker for liver fibrosis and has shown to be predictive of hepatocellular carcinoma (HCC) development.
In this webinar, Prof. Pisit Tangkijvanich, M.D. will share his experience in assessing the performance of M2BPGi as a non-invasive diagnostic and prognostic biomarker for HCC in his study cohort of patients with chronic liver disease.
We hoped you have enjoyed the webinar and gained new insights!
May we request your time for a short survey?
![[VOD AVAILABLE] Harmonisation of Discordant Notes in the Extended Lipid Panel including Lipoproteins, Apoproteins and Cardiac Markers](https://www.sysmex-ap.com/wp-content/uploads/2024/01/29135-e1705552615518-825x510.jpg)
![[VOD AVAILABLE] “Minds Together” Sysmex Knowledge Congregation – Utility of Mono-score in Infections & QMS in Medical Diagnostics Laboratories](https://www.sysmex-ap.com/wp-content/uploads/2024/01/dreamstime_l_9619043_RF-825x510.jpg)
![[VOD AVAILABLE] Experience in the Workflow and Evaluation of Invasive Breast Carcinoma](https://www.sysmex-ap.com/wp-content/uploads/2023/11/Picture1-1-e1704264341456-825x510.jpg)